Why the study?
How have cardiovascular risk factors, lifestyle, and secondary preventive medication trends changed for patients with myocardial infarction attending cardiac rehabilitation in Sweden from 2006 to 2019?
How have cardiovascular risk factors, lifestyle, and secondary preventive medication trends changed for patients with myocardial infarction attending cardiac rehabilitation in Sweden from 2006 to 2019?
Significant improvements in LDL-C, BP target achievements, and preventive medication prescriptions were observed in Swedish post-MI patients attending cardiac rehabilitation from 2006 to 2019, outperforming broader European trends.
Supports monitoring of secondary prevention metrics post-MI; leaves open targeted strategies for persistent smoking and obesity.
While little change was observed for persistent smoking and overweight/obesity, large improvements were observed for LDL-C and BP target achievements and prescription of preventive medication for Swedish patients after MI 2006-2019. Compared with published results from patients with coronary artery disease in Europe during the same period, these improvements were considerably larger. Continuous auditing and open comparisons of CR outcomes might possibly explain some of the observed improvements and differences.
No takes yet. Share an insight, caveat, or question.
Leósdóttir et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: